LYMPHOCYTE STIMULATING AGENT
LIVE

Serial Number

99085110

Owner

ImmunityBio, Inc.

Attorney

ALICIA M PASSERIN

Filing Date

Mar 14, 2025

Add to watchlist:

No watchlists yet
View on USPTO

LYMPHOCYTE STIMULATING AGENT Trademark

Serial Number: 99085110

LYMPHOCYTE STIMULATING AGENT is a trademark filed by ImmunityBio, Inc. on March 14, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

ImmunityBio, Inc. (6 trademarks)

3530 John Hopkins Court
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

March 14, 2025

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for the treatment and prevention of immunosuppressive side effects of chemotherapy, radiotherapy, and pathogenic infections

Filing History

EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
Jun 1, 2026 EXFB
NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED
Mar 3, 2026 GEA1
ACTION DENYING REQ FOR RECON E-MAILED
Mar 3, 2026 GECD
ACTION CONTINUING FINAL - COMPLETED
Mar 3, 2026 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 3, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 3, 2026 CRFA
ASSIGNED TO LIE
Mar 3, 2026 ALIE
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 2, 2026 ERFR
EX PARTE APPEAL-INSTITUTED
Mar 2, 2026 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Mar 2, 2026 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Mar 2, 2026 EXAF
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 4, 2025 GNFN
FINAL REFUSAL E-MAILED
Dec 4, 2025 GNFR
FINAL REFUSAL WRITTEN
Dec 4, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 12, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 12, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 12, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 11, 2025 GNRN
NON-FINAL ACTION E-MAILED
Aug 11, 2025 GNRT
NON-FINAL ACTION WRITTEN
Aug 11, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 5, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 14, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 14, 2025 NWOS
NEW APPLICATION ENTERED
Mar 14, 2025 NWAP